UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) March 30, 2005 (March 25, 2005)
                                                 -------------------------------
                                  GenTek Inc.
                ------------------------------------------------
               (Exact Name of Registrant as Specified in Charter)

  Delaware                        001-14789                      02-0505547
------------               ----------------------            ------------------
(State or other           (Commission File Number)           (IRS Employer
jurisdiction of                                              Identification No.)
incorporation)

                 90 East Halsey Road, Parsippany, NJ              07054
                --------------------------------------        --------------
               (Address of Principal Executive Offices)         (Zip Code)

Registrant's telephone number, including area code (973) 515-3221
                                                    -------------

                                 Not Applicable
          -----------------------------------------------------------
         (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))

<PAGE>

ITEM 5.02  DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS;
           APPOINTMENT OF PRINCIPAL OFFICERS

     Matthew R. Friel, an Executive Vice President of GenTek Inc. (the
"Company"), will be resigning effective March  31, 2005 to pursue other
interests. Mr. Friel served as the Company's Executive Vice President of Finance
and Corporate Development since August 2004, with his primary focus on leading
the Company's review of strategic alternatives. The Company's strategic review
culminated with the completion of a financing on February 28, 2005 and payment
of a $31 per share dividend to common stockholders on March 16, 2005. Mr. Friel
joined the Company in 2001, serving as Vice President and Chief Financial
Officer through August 2004.

ITEM 9.01  FINANCIAL STATEMENTS AND EXHIBITS

     (c)   Exhibits

     None.

<PAGE>

                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                        GENTEK INC.
                                        --------------------------
                                        (Registrant)


Date:  March 30, 2005           By:    /s/ Matthew M. Walsh
                                      -----------------------------------------
                                Name: Matthew M. Walsh
                                      Title: Vice President and Chief Financial
                                             Officer
[{"type": "8-K", "sequence": "1", "filename": "was5229.txt", "description": "FORM 8-K", "secsgml_size_bytes": 3726}]
{"company-data": {"conformed-name": "GENTEK INC", "cik": "0001077552", "assigned-sic": "3714", "irs-number": "020505547", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-14789", "film-number": "05714756"}, "business-address": {"street1": "LIBERTY LANE", "city": "HAMPTON", "state": "NH", "zip": "03842", "phone": "6039292606"}, "mail-address": {"street1": "C/O GENTEK INC", "street2": "90 EAST HALSEY ROAD", "city": "PARSIPPANY", "state": "NJ", "zip": "07054"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) March 30, 2005 (March 25, 2005)
                                                 -------------------------------
                                  GenTek Inc.
                ------------------------------------------------
               (Exact Name of Registrant as Specified in Charter)

  Delaware                        001-14789                      02-0505547
------------               ----------------------            ------------------
(State or other           (Commission File Number)           (IRS Employer
jurisdiction of                                              Identification No.)
incorporation)

                 90 East Halsey Road, Parsippany, NJ              07054
                --------------------------------------        --------------
               (Address of Principal Executive Offices)         (Zip Code)

Registrant's telephone number, including area code (973) 515-3221
                                                    -------------

                                 Not Applicable
          -----------------------------------------------------------
         (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.02  DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS;
           APPOINTMENT OF PRINCIPAL OFFICERS

     Matthew R. Friel, an Executive Vice President of GenTek Inc. (the
"Company"), will be resigning effective March  31, 2005 to pursue other
interests. Mr. Friel served as the Company's Executive Vice President of Finance
and Corporate Development since August 2004, with his primary focus on leading
the Company's review of strategic alternatives. The Company's strategic review
culminated with the completion of a financing on February 28, 2005 and payment
of a $31 per share dividend to common stockholders on March 16, 2005. Mr. Friel
joined the Company in 2001, serving as Vice President and Chief Financial
Officer through August 2004.

ITEM 9.01  FINANCIAL STATEMENTS AND EXHIBITS

     (c)   Exhibits

     None.
SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                        GENTEK INC.
                                        --------------------------
                                        (Registrant)

Date:  March 30, 2005           By:    /s/ Matthew M. Walsh
                                      -----------------------------------------
                                Name: Matthew M. Walsh
                                      Title: Vice President and Chief Financial
                                             Officer